Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03754179
Title Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma (COMBI-R2)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Universitair Ziekenhuis Brussel
Indications

skin melanoma

Therapies

Dabrafenib + Hydroxychloroquine + Trametinib

Age Groups: senior | adult
Covered Countries BEL

Additional content available in CKB BOOST